Jasper J L van Geel, Ndidi J Obihara, Dirk H van Rens, Marye J Boers-Sonderen, Johannes J Bonenkamp, Kalijn F Bol
{"title":"Reversal of rare paraneoplastic syndromes in melanoma: fever and cutaneous melanosis.","authors":"Jasper J L van Geel, Ndidi J Obihara, Dirk H van Rens, Marye J Boers-Sonderen, Johannes J Bonenkamp, Kalijn F Bol","doi":"10.1097/CMR.0000000000001091","DOIUrl":null,"url":null,"abstract":"<p><p>Paraneoplastic syndromes (PNS), manifestations of systemic effects of a tumor, are rare in patients with melanoma. We describe two cases of patients who presented with rare PNS, fever, and cutaneous melanosis, that resolved after treatment of melanoma. The first patient, a 64-year-old woman, presented with high fever. After diagnostic evaluation, infectious causes were excluded and the patient was diagnosed with metastatic melanoma. The fever was attributed as a PNS. After surgical removal of a large necrotic intramuscular metastasis in her leg, her fever dissolved completely, allowing continuation of immunotherapy. The second patient, a 76-year-old man, presented with a grayish skin pigmentation and dark urine and referred to the gastroenterologist. He was diagnosed with metastatic melanoma and his symptoms were recognized as cutaneous melanosis. After initiation of immunotherapy, the pigmentation gradually faded. This case series show two distinct and rare paraneoplastic phenomena in melanoma. Early recognition and tailored management of PNS is crucial, as these syndromes may obscure underlying malignancy or influence patient's overall condition. In our cases, PNS resolved after tumor-directed treatment.</p>","PeriodicalId":18550,"journal":{"name":"Melanoma Research","volume":" ","pages":"229-232"},"PeriodicalIF":1.8000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13124267/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CMR.0000000000001091","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Paraneoplastic syndromes (PNS), manifestations of systemic effects of a tumor, are rare in patients with melanoma. We describe two cases of patients who presented with rare PNS, fever, and cutaneous melanosis, that resolved after treatment of melanoma. The first patient, a 64-year-old woman, presented with high fever. After diagnostic evaluation, infectious causes were excluded and the patient was diagnosed with metastatic melanoma. The fever was attributed as a PNS. After surgical removal of a large necrotic intramuscular metastasis in her leg, her fever dissolved completely, allowing continuation of immunotherapy. The second patient, a 76-year-old man, presented with a grayish skin pigmentation and dark urine and referred to the gastroenterologist. He was diagnosed with metastatic melanoma and his symptoms were recognized as cutaneous melanosis. After initiation of immunotherapy, the pigmentation gradually faded. This case series show two distinct and rare paraneoplastic phenomena in melanoma. Early recognition and tailored management of PNS is crucial, as these syndromes may obscure underlying malignancy or influence patient's overall condition. In our cases, PNS resolved after tumor-directed treatment.
期刊介绍:
Melanoma Research is a well established international forum for the dissemination of new findings relating to melanoma. The aim of the Journal is to promote the level of informational exchange between those engaged in the field. Melanoma Research aims to encourage an informed and balanced view of experimental and clinical research and extend and stimulate communication and exchange of knowledge between investigators with differing areas of expertise. This will foster the development of translational research. The reporting of new clinical results and the effect and toxicity of new therapeutic agents and immunotherapy will be given emphasis by rapid publication of Short Communications. Thus, Melanoma Research seeks to present a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma.